%0 Journal Article
%T Effectiveness of melatonin in tardive dyskinesia Efectividad de la melatonina en la discinesia tard赤a
%A Fernando Castro
%A Edgardo Carrizo
%A Dexy Prieto de Rinc車n
%A Ciro Alberto Rinc車n
%J Investigaci車n Cl赤nica
%D 2011
%I Scientific Electronic Library Online
%X Tardive Dyskinesia (TD) is a movement disorder associated with the clinical administration of antipsychotics. It is believed that TD is due, among other factors, to an increase in the oxidative damage produced by free radicals. Antioxidants, like vitamin E, have been used in the treatment of TD but there is no evidence of their effectiveness. Melatonin (MEL) is 6 to 10 times more effective, as an antioxidant, than vitamin E and it has been used with an apparent higher effectiveness in the treatment of TD, although the results have not been conclusive. A randomized, double blind, placebo controlled design was used to determine the effectiveness of MEL (20mg/day) during 12 weeks in 7 patients with TD. Six patients with TD were treated with placebo. The Abnormal Involuntary Movement Scale (AIMS) was chosen to assess the severity of TD initially and after 4, 8 and 12 weeks. The psychiatric evaluation was done following the Brief Psychiatric Rating Scale. In two patients treated with MEL a significant improvement (more than 60%) of the values of AIMS was detected. In the remainder five, as well as in the patients treated with placebo, no difference was observed during the 12 weeks. When compared the AIMS score in all the MEL-treated patients with the values in the placebo-treated patients, no significant differences were detected during the 12 weeks of the study. However, the significant clinical improvement observed in two patients must be considered before reaching a final conclusion on the usefulness of MEL in TD. La Discinesia Tard赤a (DT) es un trastorno de los movimientos asociado al uso cr車nico de antipsic車ticos que parece producirse, entre otros factores, por un incremento en los procesos oxidativos. La vitamina E se ha utilizado en su tratamiento, pero no hay evidencia de su efectividad. Como la melatonina (MEL) es 6 a 10 veces m芍s efectiva como antioxidante que la vitamina E, se ha utilizado con una aparente mayor efectividad, aunque los resultados no han sido concluyentes. Se realiz車 un estudio doble ciego, al azar y controlado con placebo, para determinar la efectividad de la administraci車n de la MEL durante 12 semanas en 7 pacientes con DT. Seis pacientes con DT fueron tratados con placebo. La Escala de Movimientos Involuntarios Anormales (AIMS) se us車 para evaluar la evoluci車n de los movimientos al inicio y a las 4, 8 y 12 semanas de tratamiento. La evaluaci車n cl赤nica psiqui芍trica se hizo con la Escala Breve de Evaluaci車n Psiqui芍trica. En dos pacientes tratados con MEL se observ車 una mejor赤a cl赤nica superior al 60% pero en los restantes, as赤 com
%K Discinesia tard赤a
%K melatonina
%K movimientos involuntarios anormales
%K Tardive dyskinesia
%K melatonin
%K abnormal involuntary movements
%U http://wwww.scielo.org.ve/scielo.php?script=sci_arttext&pid=S0535-51332011000300006